Altered Mucosal Microbiome Diversity and Disease Severity in Sjögren Syndrome.
de Paiva CS, Jones DB, Stern ME, Bian F, Moore QL, Corbiere S, Streckfus CF, Hutchinson DS, Ajami NJ, Petrosino JF, Pflugfelder SC. · 2016
Read Altered Mucosal Microbiome Diversity and Disease Severity in Sjögren Syndrome. by de Paiva CS, Jones DB, Stern ME, Bian F, Moore QL, Corbiere S, Streckfus CF, Hutchinson DS, Ajami NJ, Petrosino JF, Pflugfelder SC. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4834578.txt.
Introduction
Cintia S. de Paiva leads a wide author team in Scientific Reports in 2016 on gut microbes in Sjögren syndrome, an autoimmune disease that dries the eyes and mouth. Gut imbalance has been tied to immune misbehavior elsewhere, so the team profiled microbes from patients' eyes, tongues, and stool, and recreated the imbalance in a mouse dry-eye model.
Patients' stool carried more of several possibly harmful genera and fewer of the usual helpful residents. The lower the gut diversity, the worse the eye and body disease scores ran. In mice, antibiotics plus drying stress produced a worse dry eye than either alone, with a matching gut shift and fewer mucus-making cells. The findings tie the syndrome to a gut pattern and suggest the gut helps set its severity.
Catalog record
| CREATOR | de Paiva CS, Jones DB, Stern ME, Bian F, Moore QL, Corbiere S, Streckfus CF, Hutchinson DS, Ajami NJ, Petrosino JF, Pflugfelder SC. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Altered Mucosal Microbiome Diversity and Disease Severity in Sjögren Syndrome By Cintia S. de Paiva, Dan B. Jones, Michael E. Stern, Fang Bian, Quianta L. Moore, Shani Corbiere, Charles F. Streckfus, Diane S. Hutchinson, Nadim J. Ajami, Joseph F. Petrosino, Stephen C. Pflugfelder Published in: Scientific Reports DOI: 10.1038/srep23561 ABSTRACT There is mounting evidence that the microbiome has potent immunoregulatory functions. We assessed the effects of intestinal dysbiosis in a model of Sjögren syndrome (SS) by subjecting mice to desiccating stress (DS) and antibiotics (ABX). We characterized the conjunctival, tongue and fecal microbiome profiles of patients with SS. Severity of ocular surface and systemic disease was graded. 16S ribosomal RNA gene sequencing characterized the microbiota. ABX + DS mice had a significantly worse dry eye phenotype compared to controls, a decrease in Clostridium and an increase in Enterobacter, Escherichia/Shigella, and Pseudomonas in stool after ABX + DS for 10 days. Goblet cell density was significantly lower in ABX treated groups compared to controls. Stool from SS subjects had greater relative abundances of Pseudobutyrivibrio, Escherichia/Shigella, Blautia, and Streptococcus, while relative abundance of Bacteroides, Parabacteroides, Faecalibacterium, and Prevotella was reduced compared to controls. The severity of SS ocular and systemic disease was inversely correlated with microbial diversity. These findings suggest that SS is marked by a dysbiotic intestinal microbiome driven by low relative abundance of commensal bacteria and high relative abundance of potentially pathogenic genera that is associated with worse ocular mucosal disease in a mouse model of SS and in SS patients. Sjögren syndrome (SS) is one of the most common mucosal autoimmune diseases with a reported prevalence of 0.09–2.7% depending on the diagnostic criteria used1. A prevalence of 1% would translate to over 4 million afflicted patients in the United States alone. SS primarily affects the secretory glands and mucosal tissues of the eye and mouth. Both the lacrimal and salivary glands become infiltrated with activated CD4+ T cells and B cells23. Ocular surface and oral mucosal disease develops from reduced lubrication, as well as from cytokines produced by activated epithelial cells and infiltrating inflammatory cells456. Salivary hyposecretion causes difficulty chewing and swallowing dry food, dental caries, and oral candidiasis7. Dry eye causes ocular symptoms including irritation, blurred and fluctuating vision and can lead to sight-threatening corneal ulceration in severe cases. Additionally, patients develop fatigue, depression, and inflammation in extraglandular tissues including the brain, lungs, and GI tract8. The disease manifestations decrease productivity and quality of life. The quality of life impact of the moderate to severe dry eye that occurs in SS was been reported to be equal to moderate to severe angina9. The overall economic burden of dry eye disease in the US is estimated at $5 billion annually due to reduced productivity and the cost of therapies10. With only one FDA approved drug for dry eye that is effective in only a subset of patients, there is a pressing need for additional therapies, particularly therapies aimed at fortifying natural immunoregulatory pathways. The glandular and mucosal immunopathological changes in SS have been thoroughly investigated311. Infiltrating CD4+ T cells and B cells replace or destroy secretory acini in the salivary and lacrimal glands. The conjunctiva is infiltrated with dendritic cells (DC) and CD4+ T cells. These T cells produce increased levels of IFN-γ and IL-17 that cause ocular surface epithelial disease. IFN-γ causes epithelial apoptosis, goblet cell loss, and increased production of cornified epithelial precursor proteins by the surface epithelium that leads to a poorly wettable skin-like surface121314. IL-17 promotes lymphangiogenesis and stimulates production of matrix metalloproteinases (MMPs) that accelerate desquamation of apical epithelial cells leading to corneal barrier disruption1516. The factors inciting this immune based mucosal inflammation are not fully understood17. The majority of primary SS patients, independent of race and ethnicity, carry the DQA1*0501 allele1819. A polymorphism in interferon response factor 5 (IRF5) has also been found to carry an increased risk for SS20. Nevertheless, not all individuals with these genetic risk factors develop disease, and the prevalence of this condition in siblings of patients with SS is no higher than the population in general21. This suggests that there are yet to be determined environmental risk factors, particularly those that may increase with age. Intestinal commensal microbiota limit colonization by enteropathogens and maintain mucosal immune homeostasis throughout the body. Commensal symbionts produce factors that support intestinal barrier function, promote generation of tolerogenic DCs and regulatory T cells (Tregs), and modulate cytokine production by NKT cells. Short chain fatty acids (SCFA), primarily butyryric acid (and to a lesser degree propionic and acetic acid) produced by fermentation of dietary starches by commensal taxa has been found to have potent immunomodulatory activity2223. Evidence suggests that intestinal dysbiosis (microbial imbalance) contributes to the pathogenesis of inflammatory bowel disease (IBD)24. Mice with antibiotic induced dysbiosis or those raised in germ-free conditions develop more severe intestinal inflammation in a dextran sodium sulfate (DSS) osmotic stress colitis model due to decreases in SCFA-producing commensal microbiota25. Furthermore, frequent antibiotic use during the first year of life was found to increase the risk of developing Crohn’s disease26, and increased adherent-invasive Escherichia coli or decreased Faecalibacterium prausnitzii, a major intestinal butyrate produce, have been associated with disease activity27. We have developed and refined an environmental mouse model of dry eye that recapitulates findings in SS. The observed changes correlate well with human disease and include: corneal barrier disruption, decreased conjunctival goblet cell density, increased CD4+ T cell infiltration in the conjunctiva, and increased expression of inflammatory cytokines and T- cell related IFN-γ and IL-17 mRNA transcripts in conjunctiva28293031. This model has been used extensively to screen compounds in pre-clinical settings30323334353637. SS affects multiple mucosal tissues and their secretory glands leading to reduced levels of innate antimicrobial factors (e.g. antimicrobial peptides and mucins)43839. We hypothesized that SS is also associated with mucosal microbial dysbiosis that could contribute to the development of autoimmune mucosal inflammation in SS. To test this hypothesis, we evaluated the effects of antibiotic-induced reduction in intestinal microbial diversity on the environmentally desiccated ocular surface in a SS mouse dry model. As a pilot study, we also investigated the ocular, oral, and stool microbiome of patients with SS. We found that depletion of the intestinal microbiome significantly worsens the ocular surface response to desiccation, and there is significantly altered diversity in the oral and intestinal microbiome in SS that is associated with disease severity. RESULTS Gut dysbiosis worsens SS-like disease in mice SS affects multiple mucosal tissues and their supporting glands. Because secretory dysfunction of these glands results in reduced levels of growth factors and innate antimicrobial factors, we hypothesized this could result in mucosal microbial dysbiosis. We evaluated the effects of antibiotic (ABX) treatment on severity of ocular disease in a validated mouse dry eye model with features of SS. This model is induced by pharmacological suppression of glandular tear secretion by cholinergic blockade and exposure to a desiccating stress (DS) environment (drafty and <30% relative humidity). Mice develop severe keratoconjunctivitis sicca with features resembling SS, including corneal barrier disruption, loss of conjunctival goblet cells, and increased expression of inflammatory and T-cell related cytokines in the conjunctiva in response to DS28293031. Our experimental design is presented in Fig. 1A. The effects of our standard DS